Sands Capital Ventures’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.4M Hold
10,950,000
4.2% 6
2025
Q1
$24M Hold
10,950,000
5.86% 5
2024
Q4
$35.6M Buy
+10,950,000
New +$35.6M 7.74% 4